Zomedica Pharma (ZOM) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Zomedica Corp. is actively engaging with NYSE American to address compliance issues after failing to meet listing standards, despite shareholders rejecting a proposed 80:1 reverse stock split. The company’s stock will remain listed as it works on measures to improve its share price and leverage its progress and future prospects to avoid delisting. Zomedica specializes in veterinary health products for animals and is committed to enhancing their care through innovative diagnostics and devices.
For further insights into ZOM stock, check out TipRanks’ Stock Analysis page.